The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway

During Leishmania infection, host immune response is important to prevent the growth/survival of intracellular amastigotes. In this study, we evaluated in vitro and in vivo whether or not during Leishmania amazonensis infection, pentavalent antimonial treatment/therapy could be more effective under TNF-alpha inhibition. Both L. amazonensis-infected macrophages (in vitro model) and mice (in vivo model) were treated with a nuclear factor-kappa B (NF-kappa B) inhibitor and with Glucantim (R) e, alone and in combined administrations. The in vitro amastigote counts, cytolcines and nitrites' production were assessed after 48 h incubation with the drugs. Paw lesion sizes and amastigote counts were also evaluated in vivo. Quantification of IL-1 beta from the infected tissue was performed. In vitro results show that when infected macrophages were incubated with QNZ + Glucantime (R), a greater clearance was observed for the amastigotes' growth and this was related to greater nitrite production compared to the group that was only infected. In vivo results show that mice that received the combined treatment had their paw lesion sizes and amastigote nests inside the macrophages greatly diminished, correlating with increased IL-1 beta levels. (C) 2015 Elsevier B.V. All rights reserved.